INCREASED PLATELET PHOSPHOLIPASE A(2) ACTIVITY IN SCHIZOPHRENIA

被引:142
作者
GATTAZ, WF
SCHMITT, A
MARAS, A
机构
[1] Neurobiology Unit, Central Institute of Mental Health, 68072 Mannheim
关键词
PHOSPHOLIPASE A(2); PLATELET; SCHIZOPHRENIA; PHOSPHOLIPID; HYPOFRONTALITY;
D O I
10.1016/0920-9964(94)00060-L
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
The intracellular enzyme phospholipase A(2) (PLA(2)) plays an essential role in the breakdown of membrane phospholipids, which regulate the physicochemical properties of the cell membrane. In the brain PLA(2) has been reported to influence receptor function and signal transduction. Regarding dopaminergic neurons, data from animal experiments and from binding studies suggest that PLA(2) activation reduces dopaminergic neurotransmission. In the present study we investigated intracellular PLA(2) in platelets from 31 DSM-III-R paranoid schizophrenic patients (15 neuroleptic-naive) compared to 31 healthy individuals and to 31 non-schizophrenic psychiatric controls, both matched to the schizophrenics by age and sex. Platelet PLA(2) activity was significantly increased in schizophrenics as compared to healthy and to psychiatric controls. Neuroleptic treatment reduced significantly the enzyme activity. Our findings in platelets suggest an accelerated breakdown of membrane phospholipids in schizophrenia. An accelerated phospholipid breakdown has also been reported in the frontal cortex from schizophrenic patients. Further studies should clarify whether increased PLA(2) in the brain, as observed in platelets, could contribute to a frontal dysfunction in schizophrenia.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 32 条
[1]  
AARSMAN AJ, 1985, BIOCHIM BIOPHYS ACTA, V837, P88
[2]  
ALBERS M, 1993, PSYCHOPHARMACOLOGY, V26, P4
[3]  
ANANDSRIVASTAVA MB, 1981, J NEUROCHEM, V36, P819
[4]   PHOSPHOLIPASE-A2 ACTIVITY IN EPSTEIN-BARR-VIRUS TRANSFORMED LYMPHOBLAST CELLS FROM SCHIZOPHRENIC-PATIENTS [J].
BENNETT, ER ;
YEDGAR, S ;
LERER, B ;
EBSTEIN, RP .
BIOLOGICAL PSYCHIATRY, 1991, 29 (11) :1058-1062
[5]   RED BLOOD-CELL ABNORMALITIES IN ALZHEIMER-DISEASE [J].
BLASS, JP ;
HANIN, I ;
BARCLAY, L ;
KOPP, U ;
REDING, MJ .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1985, 33 (06) :401-405
[6]  
BRUNNER J, 1994, IN PRESS NEURAL T
[7]  
BUTTERFIELD DA, 1980, J NEUROL SCI, V97, P261
[8]   BEHAVIORAL AND BIOCHEMICAL EFFECTS OF INTRANIGRAL INJECTION OF PHOSPHOLIPASE-A2 [J].
CADET, JL ;
HU, M ;
JACKSONLEWIS, V .
BIOLOGICAL PSYCHIATRY, 1989, 26 (01) :106-110
[9]   PHOSPHOLIPASE-A2 - FUNCTION AND PHARMACOLOGICAL REGULATION [J].
CHANG, J ;
MUSSER, JH ;
MCGREGOR, H .
BIOCHEMICAL PHARMACOLOGY, 1987, 36 (15) :2429-2436
[10]  
DEICKEN RF, 1993, BIOL PSYCHIAT, V33, pA46